NerPharMa and ICROM partner on highly potent drugs and ADC-payloads
This agreement outlines the sharing of technologies, know-how, facilities and workforce of the two companies
Breaking News
Lonza to supply prequalified cells for CN Bio OOC technology
Organ-on-a-chip technology has the potential to solve the issues presented by 2D cell cultures and animal models, the ...
WHP completes enzyme manufacturing facility for Biocatalysts
The UK-based company has worked with Biocatalysts Ltd through a stage-gated design process on a fully aseptic ...
Enesi Pharma hits milestone in thermostable solid-dose live vaccines development
Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella
Bispecific antibodies: an exciting new class of emerging therapeutics
Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...
Evonik delivers first lipids from German facility to BioNTech
The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle
DMC and Conagen partner to manufacture L-alanine
L-alanine is a naturally occurring amino acid used in homecare products, human nutrition, and pharmaceutical ...
Harnessing the power of HPAPIs: key considerations
Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider ...
CordenPharma expands lipid excipients purification
The company has been continuously investing in expanded lipid supply chain at its facilities in Switzerland, France, ...
Delegate tickets now on sale for Manufacturing Chemist Live
Taking place on 14-15 September, the event will provide a comprehensive overview on key pharmaceutical practices and ...
Accelerating excipient development for inhalable dosage forms with QbD
Whether they are simply giving an oral dose the bulk it needs to permit handling and swallowing or performing more ...
API sourcing: what to look for in a supplier
Jonathan Knight, Director of Market Intelligence and New Technologies at Cambrex, presents an overview of the API ...
Bispecific antibodies in review: from cell line development to manufacturing
With the advent of a technology that targets two different epitopes simultaneously, growth in the global bispecific ...
Recipharm and binx announce long-term supply agreement
Recipharm is a minority investor in binx health
Aker signs pharmaceutical agreement for Lysoveta therapies
Aker BioMarine will continue to seek partnerships within the pharmaceutical space to develop other therapies based on ...
In Brief
Most Popular in Ingredients
Featured Companies
Reports
